The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome.
The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome.
复制标题
螯合疗法对输血铁超负荷生存的影响:骨髓增生异常综合征的荟萃分析。
DOI:
10.1111/bjh.13053
复制
发表时间:
2014
影响因子:
6.5
通讯作者:
Coates,ThomasD
中科院分区:
文献类型:
--
作者:
Mainous3rd,ArchG;Tanner,RebeccaJ;Hulihan,MaryM;Amaya,Mirna;Coates,ThomasD
Elevated iron has been linked to increased morbidity and mortality in the general population (Mainous et al, 2004). In addition, iron overload can occur as an iatrogenic consequence of red blood cell (RBC) transfusions. Transfusional iron overload is not an uncommon consequence in patients who are chronically transfused to treat severe anaemia (de Ville de Goyet et al, 2013), as can occur in patients with myelodysplastic syndrome (MDS). Transfusion-dependent patients have increased mortality (de Ville de Goyet et al, 2013). Iron chelation therapy (ICT) is a strategy to address transfusional iron overload in MDS and utilizes drugs that remove iron as the drug is excreted.Several observational studies have examined the relationship between ICT in MDS and survival. We performed a meta-analysis of observational studies that have examined associations between ICT and survival in MDS patients, hypothesizing that patients who received ICT would have a longer median survival than patients who did not.
登录
查看更多内容
影响因子:
5.2
作者:
W. Precht
通讯作者:
W. Precht
DOI:
10.1111/j.1749-6632.1981.tb30888.x
发表时间:
1981-01-01
影响因子:
5.2
作者:
COHEN, B;HENN, V;DENNETT, D
通讯作者:
DENNETT, D
影响因子:
5.5
作者:
GONSHOR, A;MELVILLJONES, G
通讯作者:
MELVILLJONES, G
影响因子:
2.5
作者:
S. Lisberger;F. A. Miles;L. Optican;B. Eighmy
通讯作者:
B. Eighmy